Eversept Partners’s Day One Biopharmaceuticals DAWN Stock Holding History

Eversept Partners’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-183,902	Closed	-$3.94M	–	126
2026 Q1	$3.94M	Buy	+183,902	New	+$2.59M	0.21%	65

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Eversept Partners's DAWN Position: Q2 2026 in Review

Eversept Partners sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 183,902 shares — an estimated $3.94M sold.

Eversept Partners first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $3.94M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Eversept Partners reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Eversept Partners sold 183,902 Day One Biopharmaceuticals shares in Q2 2026, an estimated $3.94M.
Eversept Partners first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Eversept Partners's Day One Biopharmaceuticals position peaked at $3.94M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.